Simulations Plus, Inc. (NASDAQ:SLP) has earned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy rating.
Analysts have set a 12 month consensus target price of $18.00 for the company and are forecasting that the company will post $0.09 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Simulations Plus an industry rank of 166 out of 265 based on the ratings given to related companies.
Several equities research analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a research note on Friday. BidaskClub raised shares of Simulations Plus from a “hold” rating to a “buy” rating in a research note on Thursday, October 5th.
Simulations Plus (SLP) traded down $0.35 during trading hours on Tuesday, reaching $16.60. 40,480 shares of the company’s stock traded hands, compared to its average volume of 49,641. Simulations Plus has a one year low of $8.81 and a one year high of $17.45. The stock has a market capitalization of $286.93, a price-to-earnings ratio of 50.30 and a beta of -0.76.
Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Tuesday, November 14th. The technology company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.05 by $0.01. Simulations Plus had a net margin of 23.94% and a return on equity of 23.95%. The company had revenue of $6.30 million for the quarter, compared to analyst estimates of $5.01 million. equities research analysts anticipate that Simulations Plus will post 0.39 EPS for the current fiscal year.
In other Simulations Plus news, major shareholder Walter S. Woltosz sold 18,500 shares of the stock in a transaction dated Wednesday, September 27th. The shares were sold at an average price of $15.45, for a total value of $285,825.00. Following the completion of the sale, the insider now owns 5,647,916 shares in the company, valued at approximately $87,260,302.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders sold a total of 55,500 shares of company stock worth $880,600 over the last ninety days. 36.93% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in SLP. GSA Capital Partners LLP increased its holdings in shares of Simulations Plus by 118.7% during the 3rd quarter. GSA Capital Partners LLP now owns 47,110 shares of the technology company’s stock worth $730,000 after buying an additional 25,571 shares during the last quarter. OxFORD Asset Management LLP increased its holdings in shares of Simulations Plus by 471.6% during the 3rd quarter. OxFORD Asset Management LLP now owns 58,336 shares of the technology company’s stock worth $910,000 after buying an additional 48,131 shares during the last quarter. Cadence Capital Management LLC increased its holdings in shares of Simulations Plus by 5.1% during the 3rd quarter. Cadence Capital Management LLC now owns 116,304 shares of the technology company’s stock worth $1,803,000 after buying an additional 5,636 shares during the last quarter. Macquarie Group Ltd. acquired a new stake in shares of Simulations Plus during the 3rd quarter worth approximately $315,000. Finally, Russell Investments Group Ltd. acquired a new stake in shares of Simulations Plus during the 3rd quarter worth approximately $436,000. Institutional investors own 33.56% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/14/brokerages-set-18-00-target-price-for-simulations-plus-inc-slp.html.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Get a free copy of the Zacks research report on Simulations Plus (SLP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.